Correlation Between Monopar Therapeutics and Fennec Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and Fennec Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and Fennec Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and Fennec Pharmaceuticals, you can compare the effects of market volatilities on Monopar Therapeutics and Fennec Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of Fennec Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and Fennec Pharmaceuticals.
Diversification Opportunities for Monopar Therapeutics and Fennec Pharmaceuticals
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Monopar and Fennec is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and Fennec Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fennec Pharmaceuticals and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with Fennec Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fennec Pharmaceuticals has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and Fennec Pharmaceuticals go up and down completely randomly.
Pair Corralation between Monopar Therapeutics and Fennec Pharmaceuticals
Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 5.7 times more return on investment than Fennec Pharmaceuticals. However, Monopar Therapeutics is 5.7 times more volatile than Fennec Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Fennec Pharmaceuticals is currently generating about 0.06 per unit of risk. If you would invest 3,352 in Monopar Therapeutics on November 27, 2024 and sell it today you would earn a total of 247.00 from holding Monopar Therapeutics or generate 7.37% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Monopar Therapeutics vs. Fennec Pharmaceuticals
Performance |
| Timeline |
| Monopar Therapeutics |
| Fennec Pharmaceuticals |
Monopar Therapeutics and Fennec Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monopar Therapeutics and Fennec Pharmaceuticals
The main advantage of trading using opposite Monopar Therapeutics and Fennec Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, Fennec Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fennec Pharmaceuticals will offset losses from the drop in Fennec Pharmaceuticals' long position.| Monopar Therapeutics vs. Anebulo Pharmaceuticals | Monopar Therapeutics vs. Acrivon Therapeutics, Common | Monopar Therapeutics vs. Pmv Pharmaceuticals | Monopar Therapeutics vs. Molecular Partners AG |
| Fennec Pharmaceuticals vs. Molecular Partners AG | Fennec Pharmaceuticals vs. MediciNova | Fennec Pharmaceuticals vs. Anebulo Pharmaceuticals | Fennec Pharmaceuticals vs. Champions Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |